Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Bottom-Up

<ul>
<li>Healthy sales volume (up by 9% YoY to 512,205 MT) drive revenues in Q3FY24</li>
<li>EBITDA per ton remain subdued, but expected to steadily gather strength</li>
<li>Acquisitions coupled with ramp up of existing capacity will help take the growth story forward</li>
</ul>


Healthy sales volume (up by 9% YoY to 512,205 MT) drive revenues in Q3FY24
EBITDA per ton remain subdued, but expected to steadily gather strength
Acquisitions coupled with ramp up of existing capacity will help take the growth story forward


Jindal Stainless (JDSL IN): Steady Volume Growth- A Positive For The Long Term